BIOVECTRA
Mathew VanZant is an accomplished research scientist with extensive experience in both academic and industrial settings. Currently employed at BioVectra Inc. as a Research Scientist in R&D since November 2019, Mathew previously held the position of Analytical Chemist II at Apotex Pharmachem Inc., where responsibilities included testing and analyzing samples for major global markets and overseeing controlled substances. Mathew's earlier career includes a significant research role at the University of Waterloo, focusing on Half-Heusler materials and silicon single crystal research, along with teaching assistant duties. Mathew holds a Master’s degree in Solid State Inorganic Chemistry and a Bachelor’s degree in Honours Co-operative Chemistry from the University of Waterloo.
This person is not in any teams
BIOVECTRA
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemicaland biologic molecules, downstream processing, MPEG production, and conjugation chemistry.BioVectra was founded on 1970 and is based in Charlottetown, Canada.